Porto-Sinusoidal Vascular Disorder
Porto-Sinusoidal Vascular Disorder (PSVD) is a rare condition characterized by abnormalities in the blood vessels of the liver, which can lead to complications such as liver dysfunction and portal hypertension.
Portosinusoidal Vascular Disorder: Edoxaban Study
We are studying the safety of edoxaban in patients with Portosinusoidal Vascular Disorder. The trial also explores its potential to prevent blood clots and improve quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have any liver problems, or have you been told you have Child-Pugh Stage A or B liver function?
- Are you currently pregnant or breastfeeding?
- Have you had any major bleeding issues or are you at high risk for major bleeding?
- Are you currently taking blood thinners for conditions like atrial fibrillation or deep vein thrombosis?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Cagluen
Delianda
Ebozen
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Vienna
Department of Medicine III, Division of Gastroenterology and Hepatology
Vienna, Austria
Sponsor: Medical University Of Vienna
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.